Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: Analysis of a national clinical database, European Journal of Cancer, vol.47, issue.6, pp.910-917, 2011. ,
DOI : 10.1016/j.ejca.2010.11.014
Disparities in survival after Hodgkin lymphoma: a population-based study, Cancer Causes & Control, vol.105, issue.4, pp.1881-92, 2009. ,
DOI : 10.1007/s10552-009-9382-3
Socio-economic deprivation and survival of non-Hodgkin lymphoma in Scotland, Leukemia & Lymphoma, vol.34, issue.5, pp.917-940, 2008. ,
DOI : 10.1161/01.ATV.19.3.485
Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark ??? a nationwide study, British Journal of Cancer, vol.9, issue.5, pp.988-95, 2012. ,
DOI : 10.1038/bjc.2012.3
Improvements in Survival After Follicular Lymphoma by Race/Ethnicity and Socioeconomic Status: A Population-Based Study, Journal of Clinical Oncology, vol.27, issue.18, pp.3044-51, 2009. ,
DOI : 10.1200/JCO.2008.18.8052
Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes, International Journal of Cancer, vol.70, issue.11 ,
DOI : 10.1002/ijc.27944
Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma, Cancer, vol.40, issue.11, pp.3231-3272, 2008. ,
DOI : 10.1002/cncr.23914
Persistent socioeconomic inequalities in cancer survival in the United States: 1973?2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non- Hodgkin's lymphoma, J Registry Manag, vol.39, issue.4, pp.158-66, 2012. ,
Socioeconomic Differences in Patient Survival Are Increasing for Acute Myeloid Leukemia and Multiple Myeloma in Sweden, Journal of Clinical Oncology, vol.27, issue.12, pp.2073-80, 2009. ,
DOI : 10.1200/JCO.2008.18.2006
Effect of Place of Residence and Treatment on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma in British Columbia, The Oncologist, vol.19, issue.3, pp.283-90, 2014. ,
DOI : 10.1634/theoncologist.2013-0343
Treatment Selection and Outcomes in Early-Stage Classical Hodgkin Lymphoma: Analysis of the National Cancer Data Base, Journal of Clinical Oncology, vol.33, issue.6, pp.625-658, 2015. ,
DOI : 10.1200/JCO.2014.58.7543
Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study, Leukemia & Lymphoma, vol.35, issue.1, pp.743-51, 2013. ,
DOI : 10.1111/j.1365-2141.2007.06943.x
Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era, Blood, vol.123, issue.23, pp.3553-62, 2014. ,
DOI : 10.1182/blood-2013-07-517110
Does location matter? Rural vs urban outcomes after blood and marrow transplantation in a population-based Canadian cohort, Bone Marrow Transplantation, vol.17, issue.7, pp.1167-73, 2010. ,
DOI : 10.1038/bmt.2008.358
Survival Disparities in Patients With Lymphoma According to Place of Residence and Treatment Provider: A Population-Based Study, Journal of Clinical Oncology, vol.27, issue.32, pp.5376-82, 2009. ,
DOI : 10.1200/JCO.2009.22.0038
A longitudinal study of non-medical determinants of adherence to R-CHOP therapy for diffuse large B-cell lymphoma: implication for survival, BMC Cancer, vol.64, issue.4, pp.1-11, 2014. ,
DOI : 10.1136/jech.2008.081117
URL : https://hal.archives-ouvertes.fr/inserm-01264475
Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma, Annals of Hematology, vol.24, issue.19, pp.897-904, 2010. ,
DOI : 10.1007/s00277-010-0956-7
Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma, Journal of Experimental & Clinical Cancer Research, vol.28, issue.1, pp.1-6, 2009. ,
DOI : 10.1186/1756-9966-28-116
Breast cancer surgery: Do all patients want to go to high-volume hospitals?, Surgery, vol.143, issue.6, pp.699-705, 2008. ,
DOI : 10.1016/j.surg.2008.03.013
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group, The Lancet Oncology, vol.7, issue.5, pp.379-91, 2006. ,
DOI : 10.1016/S1470-2045(06)70664-7
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma, New England Journal of Medicine, vol.346, issue.4, pp.235-277, 2002. ,
DOI : 10.1056/NEJMoa011795
Toxicity and response criteria of the Eastern Cooperative Oncology Group, AMERICAN JOURNAL OF CLINICAL ONCOLOGY, vol.5, issue.6, pp.649-55, 1982. ,
DOI : 10.1097/00000421-198212000-00014
The international prognostic index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial, Blood, vol.92, issue.10, pp.3562-3570, 1998. ,
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era, Blood, vol.123, issue.6, pp.837-879, 2014. ,
DOI : 10.1182/blood-2013-09-524108
Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA, Haematologica, vol.96, issue.8, pp.1136-1179, 2011. ,
DOI : 10.3324/haematol.2010.038109
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial, The Lancet Oncology, vol.12, issue.5, pp.460-468, 2011. ,
DOI : 10.1016/S1470-2045(11)70069-9
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60), The Lancet Oncology, vol.9, issue.2, pp.105-121, 2008. ,
DOI : 10.1016/S1470-2045(08)70002-0
Construction of an adaptable European transnational ecological deprivation index: the French version, Journal of Epidemiology and Community Health, vol.66, issue.11, pp.982-991, 2012. ,
DOI : 10.1136/jech-2011-200311
Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variables, Cancer, vol.8, issue.6, pp.1124-1133, 1990. ,
DOI : 10.1002/1097-0142(19900915)66:6<1124::AID-CNCR2820660608>3.0.CO;2-T
R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2008. ,
Hospital and Physician Volume or Specialization and Outcomes in Cancer Treatment: Importance in Quality of Cancer Care, Journal of Clinical Oncology, vol.18, issue.11, pp.2327-2367, 2000. ,
DOI : 10.1200/JCO.2000.18.11.2327
Impact of Teaching Facility Status and High-Volume Centers on Outcomes for Lung Cancer Resection: An Examination of 13,469 Surgical Patients, Annals of Surgical Oncology, vol.34, issue.2, pp.3-13, 2009. ,
DOI : 10.1016/j.ejso.2007.08.002
Patient survival after surgical treatment of rectal cancer: Impact of surgeon and hospital characteristics, Cancer, vol.37, issue.1, pp.2472-81, 2014. ,
DOI : 10.1002/cncr.28746
Ovarian cancer in the United States: Contemporary patterns of care associated with improved survival, Gynecologic Oncology, vol.136, issue.1, pp.11-18, 2014. ,
DOI : 10.1016/j.ygyno.2014.10.023
Effect of hospital volume on processes of care and 5-year survival after breast cancer: A population-based study on 25??000 women, The Breast, vol.21, issue.3, pp.261-267, 2012. ,
DOI : 10.1016/j.breast.2011.12.002
Impact of hospital volume on breast cancer outcome: a population-based study in the Netherlands, Breast Cancer Research and Treatment, vol.248, issue.1, pp.177-84, 2014. ,
DOI : 10.1007/s10549-014-3075-7
Impact of hospital volume on outcomes of patients undergoing chemotherapy for acute myeloid leukemia: a matched cohort study, Blood, vol.125, issue.21, pp.3359-60, 2015. ,
DOI : 10.1182/blood-2015-01-625764
Effectiveness of telephone support during chemotherapy in patients with diffuse large B cell lymphoma: The Ambulatory Medical Assistance (AMA) experience, International Journal of Nursing Studies, vol.48, issue.8 ,
DOI : 10.1016/j.ijnurstu.2011.01.008
Nurse Navigators in Early Cancer Care: A Randomized, Controlled Trial, Journal of Clinical Oncology, vol.32, issue.1, pp.12-20, 2014. ,
DOI : 10.1200/JCO.2013.51.7359
Expanding access to cancer screening and clinical follow-up among the medically underserved, Cancer Pract, vol.3, issue.1, pp.19-30, 1995. ,
Effects of Nurse Navigators on Health Outcomes of Cancer Patients, Cancer Nursing, vol.34, issue.5, pp.376-84, 2011. ,
DOI : 10.1097/NCC.0b013e3182025007
Oncology Nurse Navigators and the Continuum of Cancer Care, Seminars in Oncology Nursing, vol.29, issue.2, pp.105-122, 2013. ,
DOI : 10.1016/j.soncn.2013.02.005
Predictors of physician nonadherence to chemotherapy regimens, Cancer, vol.42, issue.4, pp.945-51, 1991. ,
DOI : 10.1002/1097-0142(19910215)67:4<945::AID-CNCR2820670415>3.0.CO;2-R
Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study, Blood, vol.113, issue.22, pp.5401-5412, 2009. ,
DOI : 10.1182/blood-2008-12-196543